Relcer Gel deglycelizinated liquorice gel 400 g simethicone 100 g magnesium hydroxide 80 g aluminium hydroxide 365 g Tanzanie - angličtina - Tanzania Medicinces & Medical Devices Authority

relcer gel deglycelizinated liquorice gel 400 g simethicone 100 g magnesium hydroxide 80 g aluminium hydroxide 365 g

glenmark pharmaceuticals limited, india - magnesium , aluminium , simethicone - gel - deglycelizinated liquorice gel 400 g simethicone 100 g magnesium hydroxide 80 g aluminium hydroxide 365 g

Magnesium trisilicate compound tablets Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium trisilicate compound tablets

kent pharma (uk) ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg

Magnesium trisilicate compound tablets Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium trisilicate compound tablets

dalkeith laboratories ltd - magnesium trisilicate; aluminium hydroxide dried - oral tablet - 250mg ; 120mg

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution Spojené státy - angličtina - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

exela pharma sciences, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

Maalox Plus 200mg/175mg/25mg Oral Suspension Malta - angličtina - Malta Medicines Authority

maalox plus 200mg/175mg/25mg oral suspension

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - simethicone, aluminium hydroxide, magnesium hydroxide - oral suspension - simethicone 25 milligram(s) ; aluminium hydroxide 175 milligram(s) ; magnesium hydroxide 200 milligram(s) - drugs for acid related disorders

Maalox Plus 200mg/175mg/25mg Oral Suspension Malta - angličtina - Malta Medicines Authority

maalox plus 200mg/175mg/25mg oral suspension

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - simethicone, aluminium hydroxide, magnesium hydroxide - oral suspension - magnesium hydroxide 200 mg simethicone 25 mg aluminium hydroxide 175 mg - drugs for acid related disorders

Maalox Plus 200 mg/175 mg/25 mg Oral Suspension Irsko - angličtina - HPRA (Health Products Regulatory Authority)

maalox plus 200 mg/175 mg/25 mg oral suspension

sanofi-aventis ireland limited t/a sanofi - aluminium hydroxide; magnesium hydroxide; simeticone - oral suspension - 200 mg/175 mg/25 mg/5ml - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Kolanticon gel Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

kolanticon gel

esteve pharmaceuticals ltd - magnesium oxide light; simeticone; dicycloverine hydrochloride; aluminium hydroxide dried - oral suspension - 20mg/1ml ; 4mg/1ml ; 500microgram/1ml ; 40mg/1ml

Maalox oral suspension Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

maalox oral suspension

sanofi - magnesium hydroxide; aluminium hydroxide gel dried - oral suspension - 39mg/1ml ; 44mg/1ml